Lead Therapeutics captures $3M for cancer treatments
Lead Therapeutics, developer of medications for cancer and other infectious diseases, has roped $3 million of an expected $7 million round of debt and rights, reports VentureWire. Based in San Bruno, Calif., it previously brought in $17 million in a first round of venture funding in 2007 from Mustang Ventures, Pappas Ventures and ProQuest Investments. The company conducts most of its research and operations in China.
Next Story: iPhone 3.0 software update contains surprises, like computer tethering
Previous Story: CaliSolar shines with $60M for photovoltaic cells
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.